The VITAL study: A randomized, double-blind, placebo-controlled, global, phase III study of NEOD001 in patients with AL amyloidosis and cardiac dysfunction Meeting Abstract


Authors: Liedtke, M.; Merlini, G.; Landau, H. J.; Comenzo, R.; Seldin, D. C.; Weiss, B. M.; Zonder, J. A.; Walling, J.; Kinney, G.; Koller, M.; Gertz, M. A.
Abstract Title: The VITAL study: A randomized, double-blind, placebo-controlled, global, phase III study of NEOD001 in patients with AL amyloidosis and cardiac dysfunction
Meeting Title: 2015 Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 33
Issue: 15 Suppl.
Meeting Dates: 2015 May 29-Jun 2
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2015-05-20
Language: English
ACCESSION: WOS:000358036904876
PROVIDER: wos
Notes: Meeting Abstract: TPS8614 -- Source: Wos
MSK Authors
  1. Heather Jolie Landau
    180 Landau
Related MSK Work